Advances in Fuzzy Systems

Article Processing Charges

The charge

As an Open Access title, publishing an article in this journal requires an Article Processing Charge (APC) that will be billed to the submitting author following acceptance. Apart from this Article Processing Charge there are no other fees (for example submission charges, page charges, or color charges). 

The Article Processing Charge for the journal is $950.

Value Added Tax

Hindawi Limited is based in the United Kingdom and must charge a 20% Value Added Tax (VAT) on qualifying transactions. Where applicable, the VAT will be in addition to the APC fees indicated above. UK VAT applies when we supply services to individuals or organizations based in the UK or to non-VAT registered individuals or organizations within the EU. Transactions with VAT-registered individuals or organizations based outside the UK but within the EU are outside the scope of UK VAT. All transactions with customers outside of the EU are also outside the scope of UK VAT.

    Refund policy

    Once an article has been accepted for publication, an Article Processing Charge is due. The submitting author assumes responsibility for the Article Processing Charge, and Hindawi will not issue refunds of any kind.

      Waivers

      Hindawi operates a transparent waiver policy to help support researchers who are unable to meet some or all of the cost associated with publishing open access.

        Advances in Fuzzy Systems
         Journal metrics
        Acceptance rate13%
        Submission to final decision97 days
        Acceptance to publication41 days
        CiteScore0.510
        Impact Factor-
         Submit

        We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.